2-Chloropyrimidine → HCID 23725965, compound

HRID 2219336Notes

Reaction equation

[F:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[C:8]1[C:12]([C:13]2[N:14]=[CH:15][NH:16][CH:17]=2)=[C:11]([CH3:18])[O:10][N:9]=1.Cl[C:20]1[N:25]=[CH:24][CH:23]=[CH:22][N:21]=1>>[F:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[C:8]1[C:12]([C:13]2[N:14]=[CH:15][N:16]([C:20]3[N:25]=[CH:24][CH:23]=[CH:22][N:21]=3)[CH:17]=2)=[C:11]([CH3:18])[O:10][N:9]=1

Participants

Reactant 2

HCID 744042-Chloropyrimidine

HCID 178434991HCID 178434991, compound

Product 1

HCID 23725965HCID 23725965, compoundYield 65%

Procedure

As described for Example 36, 3-(2-fluoro-phenyl)-4-(1H-imidazol-4-yl)-5-methyl-isoxazole (100 mg, 0.41 mmol) using 2-chloropyrimidine instead of 4-fluoroacetophenone was converted to the title compound (86 mg, 65%) which was obtained as an off-white solid. MS: m/e=322.4 [M+H]+.

Sources & evidence

ORD record: ord-be2a9b48934c4696b299f5b62f2412cb
Source dataset: uspto-grants-2008_08
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US07414061B2

Reaction notes

Loading…